skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: ROAD: Directory of Open Access Scholarly Resources remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Precision oncology for BRAF-mutant cancers with BRAF and MEK inhibitors: from melanoma to tissue-agnostic therapy
Precision oncology for BRAF-mutant cancers with BRAF and MEK inhibitors: from melanoma to tissue-agnostic therapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Precision oncology for BRAF-mutant cancers with BRAF and MEK inhibitors: from melanoma to tissue-agnostic therapy

Gouda, M.A. ; Subbiah, V.

ESMO open, 2023-04, Vol.8 (2), p.100788-100788, Article 100788 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Cracking KRASG12C across all solid tumors: the new kid on the block for tissue-agnostic precision medicine
Cracking KRASG12C across all solid tumors: the new kid on the block for tissue-agnostic precision medicine
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cracking KRASG12C across all solid tumors: the new kid on the block for tissue-agnostic precision medicine

Bhamidipati, D. ; Subbiah, V.

ESMO open, 2023-08, Vol.8 (4), p.101591-101591, Article 101591 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers
Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers
Material Type:
Artigo 		Adicionar ao Meu Espaço

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

Palmeri, M. ; Mehnert, J. ; Silk, A.W. ; Jabbour, S.K. ; Ganesan, S. ; Popli, P. ; Riedlinger, G. ; Stephenson, R. ; de Meritens, A.B. ; Leiser, A. ; Mayer, T. ; Chan, N. ; Spencer, K. ; Girda, E. ; Malhotra, J. ; Chan, T. ; Subbiah, V. ; Groisberg, R.

ESMO open, 2022-02, Vol.7 (1), p.100336-100336, Article 100336 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study
Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study

Phadnis, S. ; Wang, X. ; Daw, N.C. ; Herzog, C.E. ; Subbiah, I.M. ; Zaky, W. ; Gouda, M.A. ; Morani, A.C. ; Amini, B. ; Harrison, D.J. ; Piha-Paul, S.A. ; Meric-Bernstam, F. ; Gorlick, R. ; Schwartz, C.L. ; Subbiah, V.

ESMO open, 2023-12, Vol.8 (6), p.101609-101609, Article 101609 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Differential Evolution Based IDWNN Controller for Fault Ride-Through of Grid-Connected Doubly Fed Induction Wind Generators
Differential Evolution Based IDWNN Controller for Fault Ride-Through of Grid-Connected Doubly Fed Induction Wind Generators
Material Type:
Artigo 		Adicionar ao Meu Espaço

Differential Evolution Based IDWNN Controller for Fault Ride-Through of Grid-Connected Doubly Fed Induction Wind Generators

Manonmani, N. ; Subbiah, V. ; Sivakumar, L. Sheela, Gnana

TheScientificWorld, 2015, Vol.2015, p.746017-15 [Periódico revisado por pares]

United States: Hindawi Publishing Corporation

Texto completo disponível

Citações Citado por
6
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study

Cascone, T. ; Sacks, R.L. ; Subbiah, I.M. ; Drobnitzky, N. ; Piha-Paul, S.A. ; Hong, D.S. ; Hess, K.R. ; Amini, B. ; Bhatt, T. ; Fu, S. ; Naing, A. ; Janku, F. ; Karp, D. ; Falchook, G.S. ; Conley, A.P. ; Sherman, S.I. ; Meric-Bernstam, F. ; Ryan, A.J. ; Heymach, J.V. ; Subbiah, V.

ESMO open, 2021-04, Vol.6 (2), p.100079, Article 100079 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Sodium fluoride (Na18F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors
Sodium fluoride (Na18F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sodium fluoride (Na18F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors

Kairemo, K. ; Gouda, M.A. ; Buschhorn, L. ; Wahida, A. ; Macapinlac, H.A. ; Anderson, P.M. ; Subbiah, V.

ESMO open, 2023-08, Vol.8 (4), p.101575-101575, Article 101575 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
8
Sodium fluoride (Na18F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors
Sodium fluoride (Na18F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sodium fluoride (Na18F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors

Kairemo, K. ; Gouda, M.A. ; Buschhorn, L. ; Wahida, A. ; Macapinlac, H.A. ; Anderson, P.M. ; Subbiah, V.

ESMO open, 2023-08, Vol.8 (4), p.101575, Article 101575 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket study
Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lurbinectedin, a selective inhibitor of oncogenic transcription, in patients with pretreated germline BRCA1/2 metastatic breast cancer: results from a phase II basket study

Boni, V. ; Pistilli, B. ; Braña, I. ; Shapiro, G.I. ; Trigo, J. ; Moreno, V. ; Castellano, D. ; Fernández, C. ; Kahatt, C. ; Alfaro, V. ; Siguero, M. ; Zeaiter, A. ; Longo, F. ; Zaman, K. ; Antón, A. ; Paredes, A. ; Huidobro, G. ; Subbiah, V.

ESMO open, 2022-10, Vol.7 (5), p.100571-100571, Article 100571 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response
Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response
Material Type:
Artigo 		Adicionar ao Meu Espaço

Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response

Liu, X ; George, G C ; Tsimberidou, A M ; Naing, A ; Wheler, J J ; Kopetz, S ; Fu, S ; Piha-Paul, S A ; Eng, C ; Falchook, G S ; Janku, F ; Garrett, C ; Karp, D ; Kurzrock, R ; Zinner, R ; Raghav, K ; Subbiah, V ; Hess, K ; Meric-Bernstam, F ; Hong, D S ; Overman, M J

BMC cancer, 2015-10, Vol.15 (1), p.713-713, Article 713 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (80)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (93)
  2. Reports  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2007  (6)
  2. 2007Até2010  (6)
  3. 2011Até2015  (16)
  4. 2016Até2020  (13)
  5. Após 2020  (54)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.